| dc.contributor.author | PURİSA, SEVİM | |
| dc.contributor.author | kemik, özgür | |
| dc.contributor.author | KEMİK, AHU | |
| dc.contributor.author | TÜZÜN, S | |
| dc.date.accessioned | 2021-03-03T14:21:47Z | |
| dc.date.available | 2021-03-03T14:21:47Z | |
| dc.date.issued | 2009 | |
| dc.identifier.citation | kemik ö., PURİSA S., KEMİK A., TÜZÜN S., "Increase in the circulating level of hepatocyte growth factor in pancreatic cancer patients", BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.110, sa.10, ss.627-629, 2009 | |
| dc.identifier.issn | 0006-9248 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_391ec1c9-6fa1-4d52-843b-6931ec9f7ffb | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/42429 | |
| dc.description.abstract | Objective: Hepatocyte growth factor (HGF) has been reported the cause of many biological events, including cell proliferation, invasiveness, morphogenesis, and angiogenesis. Elevated HGF content in tumor tissue was reported to predict a more aggressive biology in breast and gastric cancer patients. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | TIP, GENEL & İÇECEK | |
| dc.subject | Klinik Tıp | |
| dc.subject | Temel Tıp Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.title | Increase in the circulating level of hepatocyte growth factor in pancreatic cancer patients | |
| dc.type | Makale | |
| dc.relation.journal | BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | |
| dc.contributor.department | Istanbul Haseki Training & Research Hospital , , | |
| dc.identifier.volume | 110 | |
| dc.identifier.issue | 10 | |
| dc.identifier.startpage | 627 | |
| dc.identifier.endpage | 629 | |
| dc.contributor.firstauthorID | 637789 | |